Ardigo et al. found that plasma concentration of plasminogen-activator inhibitor-1 was only elevated in individuals with both evidence of insulin resistance and ultrasound-diagnosed fatty liver and not insulin resistance alone [22]. The gene discussed is SERPINE1; the disease is Hepatic steatosis.